CHF72.02
0.36% yesterday
SIX Swiss Exchange, Jun 06, 05:31 pm CET
ISIN
CH0432492467
Symbol
ALC

Alcon Stock price

CHF72.02
-7.62 9.57% 1M
-4.52 5.91% 6M
-4.88 6.35% YTD
-9.92 12.11% 1Y
+12.12 20.23% 5Y
+13.97 24.07% 10Y
+13.97 24.07% 20Y
SIX Swiss Exchange, Closing price Fri, Jun 06 2025
+0.26 0.36%
ISIN
CH0432492467
Symbol
ALC
Sector

Key metrics

Market capitalization CHF35.86b
Enterprise Value CHF38.97b
P/E (TTM) P/E ratio 38.93
EV/FCF (TTM) EV/FCF 32.63
EV/Sales (TTM) EV/Sales 4.78
P/S ratio (TTM) P/S ratio 4.40
P/B ratio (TTM) P/B ratio 1.97
Dividend yield 0.39%
Last dividend (FY24) CHF0.28
Revenue growth (TTM) Revenue growth 3.80%
Revenue (TTM) Revenue CHF8.16b
EBIT (operating result TTM) EBIT CHF1.15b
Free Cash Flow (TTM) Free Cash Flow CHF1.19b
Cash position CHF1.16b
EPS (TTM) EPS CHF1.85
P/E forward 37.97
P/S forward 4.11
EV/Sales forward 4.47
Show more

Create a Free Account to create an Alcon alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Alcon Stock Analysis

Unlock Scores for Free

Analyst Opinions

28 Analysts have issued a Alcon forecast:

22x Buy
79%
5x Hold
18%
1x Sell
4%

Analyst Opinions

28 Analysts have issued a Alcon forecast:

Buy
79%
Hold
18%
Sell
4%

Financial data from Alcon

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
8,158 8,158
4% 4%
100%
- Direct Costs 3,733 3,733
7% 7%
46%
4,426 4,426
1% 1%
54%
- Selling and Administrative Expenses 2,681 2,681
1% 1%
33%
- Research and Development Expense 732 732
8% 8%
9%
2,168 2,168
7% 7%
27%
- Depreciation and Amortization 1,020 1,020
2% 2%
13%
EBIT (Operating Income) EBIT 1,148 1,148
12% 12%
14%
Net Profit 921 921
7% 7%
11%

In millions CHF.

Don't miss a Thing! We will send you all news about Alcon directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Alcon Stock News

marktEINBLICKE
3 months ago
Trotz Rückruf und schwachem Schlussquartal 2024 bleibt die Wachstumsperspektive intakt. Ist jetzt ein guter Einstiegszeitpunkt für Anleger bei Alcon?

Company Profile

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the following segments: Surgical and Vision Care. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner on 1945 and is headquartered in Fribourg, Switzerland.

Head office Switzerland
CEO David Endicott
Employees 25,000
Founded 1945
Website www.alcon.ch

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today